A Message from Dr. Nancy Mendenhall I am thrilled to announce that we have reached 40% of our accrual goal! Our progress is truly astonishing, given the continued challenges COVID-19 has presented us with both globally and locally. Read Dr. Mendenhall’s message.
On February 17, 2021, Cancer Connections, a UF Monthly Educational & Networking Meeting, will present “COMPPARE Clinical Trial: Protons vs Photons to Treat Prostate Cancer” from noon to 1 pm (EST). Dr. Nancy Mendenhall, M.D., FACR, FASTRO, COMPPARE Principal Investigator, will discuss the UF-led national ongoing prostate cancer clinical trial.
The COMPPARE team was pleased to announce on November 13, 2020 that the study had enrolled 1,000 patients, one-third of its 3,000-patient goal. COMPPARE’s partner site, the James M. Slater, MD Proton Treatment & Research Center, Loma Linda, CA, enrolled the 1,000th patient. COMPPARE stands for “A Prospective COMparative Study…
Mr. Charles Griggs and Drs. Nancy Mendenhall and Curtiland Deville participated in “Our Health, Our Voice: Improving Prostate Cancer Outcomes through Participation in Research” on Wednesday, November 4, 2020. The live information session, presented by 100 Black Men of America, Inc., a COMPPARE partner organization, focused on the…
We look forward to sharing our patient-centric news with you. Below you can find an archive of our issues: Our latest COMPPARE Connection Issue COMPPARE Connection: Issue 3, Fall 2020 COMPPARE Connection: Issue 2, Summer 2020…
A Message from Dr. Nancy Mendenhall Despite the challenges that we and other cancer research studies continue to face in this unprecedented time of COVID-19, COMPPARE has made significant progress toward our ultimate goal of helping prostate cancer patients make informed treatment decisions. Read…
English Version Download PDF Spanish Version Download PDF…
English and spanish versions COMPPARE Brochures Learn why this study will help future patients make evidence-based treatment decisions.
Step 1: Meet with your Radiation Oncologist and the study staff to determine if COMPPARE is right for you. If so, in Step 2, give your consent to participate and register for the study. Step 3: Complete the Pretreatment Questionnaires. Step 4: Receive the radiation…
